The first efficacy endpoint was change from baseline MADRS score. This small-phrase research discovered that, compared to intranasal placebo furthermore oral antidepressant, intranasal esketamine in conjunction with an oral antidepressant appreciably enhanced depressive indicators soon after 4 months by a indicate distinction of 4 details to the MA… Read More